Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Capital Expenditures (2020 - 2022)

Bio Essence has reported Capital Expenditures over the past 3 years, most recently at -$49851.0 for Q4 2022.

  • For Q4 2022, Capital Expenditures fell 155.48% year-over-year to -$49851.0; the TTM value through Dec 2023 reached $92049.0, down 8.92%, while the annual FY2023 figure was $3614.0, 3.42% down from the prior year.
  • Capital Expenditures for Q4 2022 was -$49851.0 at Bio Essence, down from $52053.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $89847.0 in Q4 2021 and troughed at -$49851.0 in Q4 2022.
  • A 3-year average of $18206.6 and a median of $9537.0 in 2021 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: soared 1463.1% in 2021 and later tumbled 155.48% in 2022.
  • Year by year, Capital Expenditures stood at $5748.0 in 2020, then soared by 1463.1% to $89847.0 in 2021, then tumbled by 155.48% to -$49851.0 in 2022.
  • Business Quant data shows Capital Expenditures for BIOE at -$49851.0 in Q4 2022, $52053.0 in Q3 2022, and $89847.0 in Q4 2021.